Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Phytopharm opens new facility for manufacture of antiobesity drug

April 16, 1999

Jenapharm's scavestrogen is more potent than estrogen in preventing atherosclerosis

April 16, 1999

Presence of GHRH receptor is essential for response to treatment with GHRPs

April 16, 1999

Estrogen/antiandrogenic progesterone combination for hirsutism: efficacy of long-term Rx

April 16, 1999

New series of osteogenesis-promoting agents developed at Taisho

April 16, 1999

Preclinical and clinical results support efficacy of Trovert in treatment of acromegaly

April 16, 1999

U.K. team develops novel male contraceptive methodology

April 16, 1999

Celtrix and Elan form joint venture for osteoporosis therapy

April 15, 1999

Orquest's bone substitute product approved in E.C.

April 14, 1999

Novel Roche peptides useful for bone disorders

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...